Brain tumour surgery: Triumphs and tragedies

Journal of the Royal College of Surgeons of Edinburgh

Volumn 44, Issue 2, 1999, Pages 72-77

  Whittle, Ian R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glioma; Neuro oncology; Neurology; Neurosurgery; Specialisation; Sub specialty

Indexed keywords

BRAIN TUMOR; CANCER CENTER; CANCER SURGERY; CANCER SURVIVAL; GLIOMA; HUMAN; NEUROSURGERY; REVIEW;

BRAIN NEOPLASMS; GLIOMA; HEALTH CARE COSTS; HUMANS; NEUROSURGICAL PROCEDURES; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032951636     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Miller JD. Neurosurgery - Triumphs and tragedies. J Roy Coll Surg Edin 1983; 28: 1-7
2. Nicholl JA, Roberts GW, Graham DI. Amyloid beta protein, APOE genotype and head injury. Annal NY Acad Sci 1996; 777; 271-53
3. Ostertag C. Sub-specialty training in Neurosurger. Acta Neurochir 1997; 69 (Suppl): 126-9
4. Davenport RJ, Dennis MS, Warlow CP. Effect of correcting outcome data for case mix: an example from stroke medicine. Brit Med J 1996; 313: 1005-6
5. Maurice-Williams RS. The notes in the cupboard; the question of intellectual dishonesty in Neurosurgery. Brit J Neurosurg 1997; 11: 277-279
6. Rothwell P, Warlow CP. Is self-audit reliable . Lancet 1995; 346: 1623
7. Moher B, Pham Ba, Jones A et al. Does quality of report of randomised trials affect estimate of intervention efficacy reported in meta-analyses. Lancet 1998; 352: 609-13
8. Schiller F. Early approaches to brain tumours. Neurosurgery 1996; 38: 1023-1030
9. Bennett AH, Godlee RJ. Case of cerebral tumour. Br Med J; 1885(1): 988-989
10. Ligon BL. The mystery of angiography and the unawarded Nobel Prize. Egas Moniz and Hans-Christian Jacobaeus. Neurosurgery 1998; 43: 602-12
11. Hounsfield GN. Computerised tomographic axial scanning (tomography).1 Description of the system. Brit J Radiol 1973; 46: 1016-23
12. Galicich JH, French LA, Melby JC. Use of dexamethasone in the treatment of cerebral edema associated with brain tumours. Lancet 1961; 81: 46-53
13. Beks JWF, Doorenbos H, Walstra GJM. Clinical experience with steroids in neurosurgical patients. In Reulen HJ, Schurmann K (Ed's) Steroids and brain edema, Springer, Berlin, 1972, 233-238
14. Maxwell RE, Long DM, French LA. The clinical effects of a synthetic gluco-corticoid used in for brain edema in the practice of Neurosurgery. In Reulen HJ, Schurmann K (Ed's) Steroids and brain edema, Springer, Berlin, 1972, 219-32
15. Whittle I R, Viswanathan R. Acute intraoperative brain swelling complicating elective Neurosurgery; Pathophysiological and management considerations. J Neurol Neurosurg Psychiat 1996; 61:584-590
16. Bramwell B Intracranial Tumours, Edinburgh, Pentland. Quoted in ref 8.
17. Hitchcock ER, Sato F. Treatment of malignant glioma. J Neurosurg 1964; 21; 497-505
18. Apuzzo MLJ, Chandrasoma T, Cohen D et al. Computer imaging stereotaxy; experience and perspectives related to 500 procedures applied to brain masses. Neurosurgery 1987; 20; 930-937
19. Whittle I R, Denholm S, El Shunnar K. CT imaged guided stereotaxic Neurosurgery using the Brown-Roberts-Wells system: Experience with 125 procedures. Aust NZ J Surg 1991; 61; 919-928
20. Sabin H I, Whittle I R. Stereotaxic craniotomy and intraoperative lesion localization using the Brown-Roberts-Wells system. Technical note. Acta Neurochir (Wien) 1990; 102: 137-140
21. Kelly PJ, Balll BA, Goerss Sj et al. Results of computer assisted stereotactic laser resection of deep seated intracranial lesions. Mayo Clin Proc 1987; 61: 20-27
22. Sandeman D, Patel N, Chandler C et al. Advances in image guided Neurosurgery: preliminary experience with the ISG viewing wand compared to the Leksell G frame. Brit J Neurosurg 1994; 8: 529-44
23. Dorward N. Neuronavigation - the surgeons sextant. Brit J Neurosurg 1997; 11: 101-103
24. Black PM, Moriarty T, Alexander E, et al. Development and implementation of intraoperative MRI its neurosurgical application. Neurosurgery 1997; 41: 831-42
25. Cabantog A, Bernstein M. Complications of first craniotomy for intra-axial brain tumour. Can J Neurol Sci 1994; 21: 213-21,
26. Whittle IR. Neuronavigation: where is the evidence and will there ever be any? Brit J Neurosurg. 1998; 12; 96-70
27. Latif AZ, Signorini D, Grant R, Gregor A, Whittle IR. Application of the MRC prognostic index to patients with malignant brain tumours in Edinburgh. J Neurol. Neurosurg. Psychiat.1998; 64: 747-750
28. Kirby S, Brothers M, Irish W et al. Evaluating glioma therapy; modelling treatment and predicting outcome. J Nat Cancer Inst 1995; 87: 1884-8
29. Grant R, Whittle I R, Collie D et al. Referral patterns and treatment delays in patients with brain tumours; an audit of cases diagnosed in the south east of Scotland during 1989 and 1990. Health Bulletin 1996; 54;209-222
30. Latif AZ, Signorini D, Whittle IR. Treatment by specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma. Brit. J. Neurosurg.1998; 12: 29-32.
31. Stone R. Molecular Surgery for brain tumours. Science 1994; 86: 82-83
32. Culver KW, Ram Z, Walbridge S et al. In vio gene transfer with retroviral vector producing cells for the treatment of experimental brain tumours. Science 1992; 256; 1550-52
33. Ram Z, Culver KW, Oshiro EM et al. Therapy of malignant brain tumours by intratumoural implantation of retroviral vector-producing cells. Nature Med 1997; 3: 1354-61
34. Bell HS, Kimber W L, Li M, Whittle IR, Liposomal transfection efficiency and toxicity on glioma cell lines and brain; in vitro and in vivo studies. Neuroreport, 1998; 9:793-798
35. Pilkington GJ. Tumour cell migration in the central nervous system. Brain Pathol 1994; 4:157-166,
36. Burger PC, Dubois PJ, Schold SC et al. Computerized tomographic and pathological studies of the untreated, quiescent and recurrent glioblastoma multiforme. J Neurosurg 1983; 58: 159-169
37. Kleihues P, Burger PC, Plate KH, Ohgaki H, Cavenee W. Glioblastoma. In Klieshues P and Cavenee WK (Edit's) Pathology and genetics of tumours of the nervous system. International Agency for research on Cancer, Lyon,1997; 16-24
38. Whittle IR, Thomson AM, Taylor R. The effects of resective surgery for left sided intracranial tumours on language function: a prospective study. Lancet 1998; 351: 1014-1018
39. Thomas DGT, Bleehan NM, Roberts JT et al. MRC Randomised trial of adjuvant chemotherapy in high grade glioma (HGG-BR5). J Neuro-oncol 1998; 39: 102
40. Latif AZ, Signorini D, McGregor K, Grant R, Gregor A, Whittle IR. The costs of managing patients with malignant glioma at a neuro-oncology clinic. Brit. J. Neurosurg. 1998; 12: 118-12,
41. Laske DW, Youle RJ, Oldfield EH. Tumour regression with regional distribution of the targetted toxin TF-CRM107 in patients with malignant brain tumours. Nat Med 1997; 3: 1362-68
42. Soloway AH, Barth RF, Gahbauer RA et al,. The rationale and requirements for the development of Boron Neutron Capture Therapy for brain tumours. J Neuro-Oncol 1997; 33: 9-18
43. Brem H, Piantadosi S, Burger PC et al. Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995; 345: 1008-1012
44. Grant R, Slattery J, Gregor A, et al. Recording neurological impairment in clinical trials of glioma. J Neuro-oncol 1994; 19: 37-49
45. Gregor A, Rampling R, Aapro M, Maelstrom P, Whittle I R et al. Phase II study of TCNU (tauromustine) in malignant glioma. Eur J Cancer 1992; 28A: 1959-62
46. Davies E, Hopkins A. on behalf of a working party. Good practice in the management of adults with malignant glioma; clinical guidelines Brit J Neurosurg 1997; 11: 318-330